The Effectiveness of Endoscopic Gastroplasty for Obesity Treatment According to FDA Thresholds: Systematic Review and Meta-Analysis Based on Randomized Controlled Trials

Obes Surg. 2018 Sep;28(9):2932-2940. doi: 10.1007/s11695-018-3335-4.

Abstract

Endoscopic bariatric therapies (EBTs) are promising alternatives to conventional surgery for obesity. The aim of this study is to compare efficacy and safety through a systematic review and meta-analysis of the endoscopic gastroplasty techniques versus conservative treatment. We searched MEDLINE, EMBASE, Cochrane CENTRAL, Lilacs/Bireme. Randomized controlled trials (RCTs) enrolling obese patients comparing endoscopic gastroplasty to sham or diet/exercise were considered eligible. Among 6014 records, three RCTs were selected for meta-analysis. The total sample was 459 patients (312 EBTs vs 147 control). Mean total body weight loss in the intervention group (IG) was 4.8% higher than the control group (CG) at 12 months (p = 0.01). The IG responder rate was 44.31% at 12 months. Therefore, the endoscopic gastroplasty is more effective than conservative therapies but do not achieve FDA thresholds.

Keywords: Endoluminal therapy; Endoscopic suture; Endoscopic therapy; Endoscopy; Gastroplasty; Meta-analysis; Obesity; Systematic review.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Endoscopy*
  • Gastroplasty / methods*
  • Humans
  • Obesity / surgery*
  • Randomized Controlled Trials as Topic
  • Weight Loss